Free Trial

Legal & General Group Plc Purchases 213,041 Shares of Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Legal & General increased its stake in Synopsys by 19.9%, buying 213,041 shares to own 1,283,393 shares (about a 0.69% stake) valued at roughly $633.2 million at quarter-end.
  • Strong quarterly results: Synopsys reported $3.77 EPS vs. $3.56 expected and $2.41B revenue (vs. $2.39B), with revenue up 65.6% year‑over‑year and FY2026 EPS guidance of $14.380–$14.460.
  • Analyst sentiment is mixed: the consensus is a "Hold" with an average target of $531, comprising 8 Buy, 8 Hold and 1 Sell ratings.
  • MarketBeat previews the top five stocks to own by May 1st.

Legal & General Group Plc increased its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 19.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,283,393 shares of the semiconductor company's stock after acquiring an additional 213,041 shares during the quarter. Legal & General Group Plc owned about 0.69% of Synopsys worth $633,213,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of SNPS. Brighton Jones LLC lifted its position in shares of Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock worth $447,000 after purchasing an additional 50 shares during the last quarter. Integrated Wealth Concepts LLC grew its holdings in Synopsys by 11.6% in the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company's stock valued at $326,000 after buying an additional 79 shares during the last quarter. NewEdge Advisors LLC increased its position in Synopsys by 15.1% in the 1st quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company's stock worth $1,291,000 after buying an additional 395 shares during the period. Savant Capital LLC lifted its holdings in shares of Synopsys by 8.2% during the second quarter. Savant Capital LLC now owns 5,125 shares of the semiconductor company's stock worth $2,627,000 after buying an additional 387 shares during the last quarter. Finally, AE Wealth Management LLC lifted its holdings in shares of Synopsys by 31.5% during the second quarter. AE Wealth Management LLC now owns 6,257 shares of the semiconductor company's stock worth $3,208,000 after buying an additional 1,499 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on SNPS shares. HSBC downgraded shares of Synopsys from a "buy" rating to a "hold" rating and set a $455.00 price objective on the stock. in a research note on Friday, February 20th. Wall Street Zen raised shares of Synopsys from a "sell" rating to a "hold" rating in a report on Saturday, December 13th. Citigroup assumed coverage on shares of Synopsys in a research report on Monday, November 24th. They issued a "buy" rating and a $580.00 price target on the stock. The Goldman Sachs Group set a $600.00 price objective on shares of Synopsys and gave the stock a "buy" rating in a report on Wednesday, February 25th. Finally, Piper Sandler cut their price objective on shares of Synopsys from $520.00 to $430.00 and set a "neutral" rating for the company in a research report on Thursday, February 26th. Eight research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $531.00.

View Our Latest Analysis on SNPS

Synopsys Trading Down 1.0%

SNPS stock opened at $432.65 on Wednesday. The company has a current ratio of 1.36, a quick ratio of 1.26 and a debt-to-equity ratio of 0.33. The firm has a market cap of $82.88 billion, a P/E ratio of 67.18, a P/E/G ratio of 3.56 and a beta of 1.15. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The business's 50 day moving average is $465.04 and its 200-day moving average is $466.42.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, beating the consensus estimate of $3.56 by $0.21. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The business had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.39 billion. During the same quarter in the previous year, the firm earned $3.03 EPS. Synopsys's quarterly revenue was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Equities analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Buying and Selling at Synopsys

In related news, CFO Shelagh Glaser sold 3,657 shares of the firm's stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Janet Lee sold 250 shares of Synopsys stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares of the company's stock, valued at approximately $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 4,157 shares of company stock worth $1,945,036 in the last 90 days. 0.56% of the stock is owned by corporate insiders.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines